India Exchange Filings

Gland Pharma Q2 FY27 Investor Presentation

Gland Pharma Ltd reports Q2 FY27 revenue of ₹1,833.6 crore, up 23% YoY

  • EBITDA margin was 26%, versus 21% in Q2 FY26 and 27% in Q1 FY27.
  • Net profit was ₹290.8 crore, up 58% YoY and down 8% sequentially.
  • Presentation reported no exceptional items or auditor qualifications.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.